Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab

BACKGROUND: Clinical targeting of TNFR family of receptors (CD40, CD134 and CD137) with immunostimulatory monoclonal antibodies has been successful in cancer immunotherapy. However, targeting of CD27 with a mAb is a relatively new approach to provide costimulation of immune cells undergoing activati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishna, Venky, Sundarapandiyan, Karuna, Zhao, Biwei, Bylesjo, Max, Marsh, Henry C., Keler, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619281/
https://www.ncbi.nlm.nih.gov/pubmed/26500773
http://dx.doi.org/10.1186/s40425-015-0080-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619281/
https://www.ncbi.nlm.nih.gov/pubmed/26500773
http://dx.doi.org/10.1186/s40425-015-0080-2

Ejemplares similares